RSS   Newsletter   Contact   Advertise with us
Post Online Media
LogicBio Therapeutics appoints Dean Falb as chief scientific officer POST Online Media

LogicBio Therapeutics appoints Dean Falb as chief scientific officer

Staff Writer | Cambridge, Mass., USA | Friday May 25, 2018 7:57AM ET
LogicBio TherapeuticsLogicBio Therapeutics, a genetic medicine company, announced the appointment of Dean Falb as chief scientific officer.


Dr. Falb, who most recently served as chief technology officer at Synlogic Therapeutics, brings more than 20 years of drug discovery and development experience to the LogicBio leadership team.

Prior to Synlogic, Dr. Falb was an entrepreneur in residence at Atlas Ventures, where he helped guide the launch of several early stage life sciences companies.

From 2005 to 2012, he served as vice president of research at Stryker Regenerative Medicine.

In this role, he led the discovery and development of a portfolio of bone morphogenic protein drugs in osteoarthritis.

Dr. Falb has also held leadership positions at Praecis Pharmaceuticals, Inc., NeoGenesis Pharmaceuticals, Inc., and Millennium Pharmaceuticals, Inc.

He received his doctoral degree in biochemistry and molecular biology from Harvard University.

 

 LATEST MOVES FROM Massachusetts